(Q52544855)

3 May 2018

title

Concurrent inactivation of RB1 and TP53 pathways in anaplastic oligodendrogliomas. (English)

1 reference

3 May 2018

1 reference

Watanabe T

1

1 reference

3 May 2018

Yokoo H

2

1 reference

3 May 2018

Yokoo M

3

1 reference

3 May 2018

Yonekawa Y

4

1 reference

3 May 2018

Kleihues P

5

1 reference

3 May 2018

Ohgaki H

6

1 reference

3 May 2018

publication date

1 December 2001

1 reference

3 May 2018

Journal of Neuropathology & Experimental Neurology

published in

1 reference

3 May 2018

volume

60

1 reference

3 May 2018

page(s)

1181-1189

1 reference

3 May 2018

issue

12

1 reference

3 May 2018

Oligodendroglioma: incidence and biological behavior in a defined population

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.12.1181

Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.12.1181

Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.12.1181

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.12.1181

Identification of subgroups of high-grade oligodendroglial tumors by comparative genomic hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.12.1181

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.12.1181

The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.12.1181

CDK inhibitors: positive and negative regulators of G1-phase progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.12.1181

p16(INK4a) and the control of cellular proliferative life span.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.12.1181

p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.12.1181

Regulation of the G2/M transition by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.12.1181

Pathways governing G1/S transition and their response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.12.1181

21 January 2018

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.12.1181

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.12.1181

Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.12.1181

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.12.1181

ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.12.1181

Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.12.1181

Functional evidence for a role of combined CDKN2A (p16-p14(ARF))/CDKN2B (p15) gene inactivation in malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.12.1181

Alterations of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.12.1181

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.12.1181

Promoter hypermethylation of the RB1 gene in glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.12.1181

Genetic alterations associated with the evolution and progression of astrocytic brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.12.1181

Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.12.1181

Infrequent alterations of the p15, p16, CDK4 and cyclin D1 genes in non-astrocytic human brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.12.1181

Preferential inactivation of the p53 tumor suppressor pathway and lack of EGFR amplification distinguish de novo high grade pediatric astrocytomas from de novo adult astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.12.1181

Concurrent disruption of p16INK4a and the ARF-p53 pathway predicts poor prognosis in aggressive non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.12.1181

Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.12.1181

p53 and E2F-1 cooperate to mediate apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.12.1181

p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.12.1181

Cellular response to oncogenic ras involves induction of the Cdk4 and Cdk6 inhibitor p15(INK4b)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.12.1181

21 January 2018

Identifiers

DOI

10.1093/JNEN/60.12.1181

1 reference

3 May 2018

release_6hjsr2vumrezpktbuy4beferjq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6hjsr2vumrezpktbuy4beferjq

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

11764090

1 reference

3 May 2018